Frances Priddy

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

Laura M. Walker, Sanjay Phogat, Po-Ying Chan-Hui et al. · Science · 2009 · 1.7K citations

Life Sciences, Immunology, Infectious Diseases +17

Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm

Melissa Simek, Wasima Rida, Frances Priddy et al. · Journal of Virology · 2009 · 581 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals

Laura M. Walker, Melissa Simek, Frances Priddy et al. · PLoS Pathogens · 2010 · 373 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H. Barouch, Frank Tomaka, Frank Wegmann et al. · The Lancet · 2018 · 342 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

High Acceptability of HIV Pre-exposure Prophylaxis but Challenges in Adherence and Use: Qualitative Insights from a Phase I Trial of Intermittent and Daily PrEP in At-Risk Populations in Kenya

Elisabeth M. van der Elst, Judie Mbogua, Don Operario et al. · AIDS and Behavior · 2012 · 276 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +17